The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
New risk sharing models align the economics of an agreement to product or service performance and outcomes. In this webinar, we discuss this…
Book
AHRMM created this book for engaged and motivated supply chain leaders in the making.
Book
This manual is divided into four distinct units, which include: Materials Management Organization and Administration, Materials Management Functional…
Podcasts
A short introduction to the CMS Meaningful Use 3 Rule and how implementing UDI within the healthcare setting and moving toward the full GS1 will re
On-Demand Educational Webinars
In this webinar, we discuss the clinical contract evaluation process, including government requirements, expectations, and improving contract…